Thyroid News

Adults with differentiated thyroid cancer aged at least 55 years are more likely to experience disease recurrence and at a quicker rate than those who are younger, supporting the use of age as a factor in risk assessment, according to findings published in Thyroid.

Adults with medullary thyroid cancer who develop osteolytic bone metastases are more likely to experience skeletal-related adverse events compared with similar patients who develop osteoblastic bone metastases, suggesting that antiresorptive therapies should be considered based on the morphology of disease, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Adults with hypothyroidism taking levothyroxine therapy may derive a greater benefit when taking the drug at bedtime vs. before breakfast, according to findings published in Clinical Endocrinology.

Adults who undergo thyroid surgery for noncancerous indications are more likely to have incidental findings of papillary thyroid cancer if they have chronic lymphocytic thyroiditis than either multinodular goiter or Graves’ disease, according to findings published in Thyroid.

Physicians who treat patients with hypothyroidism should opt for levothyroxine monotherapy in most patients, and when treating patients with Graves’ disease, radioactive iodine is the optimal treatment option, according to a summary of new National Institute for Health and Care Excellence, or NICE, guidelines published in The BMJ.

A 27-year-old woman with no significant medical history presented to our institution for management of her thyroid cancer.

Adults with radioactive iodine-refractory thyroid cancer and sarcopenia who are treated with sorafenib are no more likely to experience a dose modification due to drug toxicity than a similar patient without sarcopenia, according to findings from an exploratory analysis of the DECISION trial.

Thyroid dysfunction is common among people with diabetes regardless of type, suggesting that biochemical thyroid screening should be a part of routine management for those with type 1 and type 2, according to an analysis of a community-based study published in Clinical Endocrinology.

In a large prospective cohort of postmenopausal women, those who had ever had hypothyroidism — whether treated with levothyroxine or not — were less likely to develop breast cancer than those without hypothyroidism, and the relationship was more pronounced among those who did not also use menopausal hormone therapy, according to findings published in Thyroid.

Women with Hashimoto’s thyroiditis plus a non-endocrine autoimmune disorder were more likely to have multiple miscarriages than those with Hashimoto’s thyroiditis, according to findings published in Thyroid.